Related Experiment Video
Updated: Jun 2, 2026

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
Published on: May 12, 2020
The anti-cancer agent guttiferone-A permeabilizes mitochondrial membrane: ensuing energetic and oxidative stress
Gilberto L Pardo-Andreu1, Yanier Nuñez-Figueredo, Valeria G Tudella
1Centro de Estudio para las Investigaciones y Evaluaciones Biológicas, Instituto de Farmacia y Alimentos, Universidad de La Habana, Ave. 23 # 21425 e/214 and 222, La Coronela, La Lisa, CP 13600, Ciudad Habana, Cuba. gilbertopardo@infomed.sld.cu
Abstract:
Guttiferone-A (GA) is a natural occurring polyisoprenylated benzophenone with cytotoxic action in vitro and anti-tumor action in rodent models. We addressed a potential involvement of mitochondria in GA toxicity (1-25 μM) toward cancer cells by employing both hepatic carcinoma (HepG2) cells and succinate-energized mitochondria, isolated from rat liver. In HepG2 cells GA decreased viability, dissipated mitochondrial membrane potential, depleted ATP and increased reactive oxygen species (ROS) levels. In isolated rat-liver mitochondria GA promoted membrane fluidity increase, cyclosporine A/EGTA-insensitive membrane permeabilization, uncoupling (membrane potential dissipation/state 4 respiration rate increase), Ca²⁺ efflux, ATP depletion, NAD(P)H depletion/oxidation and ROS levels increase. All effects in cells, except mitochondrial membrane potential dissipation, as well as NADPH depletion/oxidation and permeabilization in isolated mitochondria, were partly prevented by the a NAD(P)H regenerating substrate isocitrate. The results suggest the following sequence of events: 1) GA interaction with mitochondrial membrane promoting its permeabilization; 2) mitochondrial membrane potential dissipation; 3) NAD(P)H oxidation/depletion due to inability of membrane potential-sensitive NADP+ transhydrogenase of sustaining its reduced state; 4) ROS accumulation inside mitochondria and cells; 5) additional mitochondrial membrane permeabilization due to ROS; and 6) ATP depletion. These GA actions are potentially implicated in the well-documented anti-cancer property of GA/structure related compounds.
Insights
Guttiferone-A (GA) causes cancer cell death by damaging mitochondria, leading to energy depletion and reactive oxygen species (ROS) production. These mitochondrial effects explain GA's anti-cancer properties.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Guttiferone-A (GA), a natural benzophenone, exhibits cytotoxic and anti-tumor effects.
- Mitochondria play a crucial role in cellular energy production and apoptosis.
Purpose of the Study:
- To investigate the role of mitochondria in Guttiferone-A-induced cancer cell toxicity.
- To elucidate the mechanism of Guttiferone-A action at the mitochondrial level.
Main Methods:
- Experiments were conducted using hepatic carcinoma (HepG2) cells and isolated rat liver mitochondria.
- Assessed cellular viability, mitochondrial membrane potential, ATP levels, reactive oxygen species (ROS) production, and mitochondrial membrane permeability.
- Utilized succinate as an energy substrate and isocitrate for NAD(P)H regeneration.
Main Results:
- Guttiferone-A decreased HepG2 cell viability, dissipated mitochondrial membrane potential, depleted ATP, and increased ROS.
- In isolated mitochondria, GA increased membrane fluidity, induced permeabilization, caused uncoupling, and promoted Ca²⁺ efflux, ATP/NAD(P)H depletion, and ROS generation.
- Isocitrate partially prevented most GA-induced effects, suggesting NAD(P)H's protective role.
Conclusions:
- Guttiferone-A initiates toxicity by permeabilizing mitochondrial membranes, leading to a cascade of damaging events including potential dissipation, NAD(P)H oxidation, ROS accumulation, and ATP depletion.
- These mitochondrial disruptions are key to Guttiferone-A's cytotoxic action and potential anti-cancer efficacy.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mitochondrial Membranes

